Neoplasm Metastasis: all 3,564 studies
Page 5 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PETNot yet recruitingNCT06511323Not applicable
- Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.Not yet recruitingNCT06510946Not applicable
- Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood CollectionEnrolling by invitationNCT06508138Phase 1
- Safety and Efficacy of KLS-1 Monotherapy in Malignant NeoplasmsRecruitingNCT06506643Phase 1/2
- Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain MetastasisRecruitingNCT06501391Phase 2
- CALM Psychotherapy in Patients With Metastatic Cancer in ChileRecruitingNCT06501261Not applicable
- A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant TumorsNot yet recruitingNCT06496919
- Prospective Observational Cohort StudyNot yet recruitingNCT06493448
- Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative GenesNot yet recruitingNCT06490913Phase 2
- Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal MetastasisEnrolling by invitationNCT06487715Phase 2
- TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant TumorsRecruitingNCT06487663Not applicable
- Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension StudyNot yet recruitingNCT06487026Not applicable
- Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal StudyRecruitingNCT06487013Not applicable
- Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual StainingNot yet recruitingNCT06486155
- Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain MetastasesNot yet recruitingNCT06483672Phase 2
- Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver EnzymeRecruitingNCT06475352Phase 2
- Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer PatientsRecruitingNCT06473259
- Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of PatientsRecruitingNCT06468696Not applicable
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain MetastasesNot yet recruitingNCT06462079Phase 2
- Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.RecruitingNCT06448897
- Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKINot yet recruitingNCT06441045Phase 2
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsRecruitingNCT06440005Phase 1
- Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.Not yet recruitingNCT06435741Not applicable
- Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain MetastasisRecruitingNCT06418594Phase 2
- Standardized Clinical Assessment of Patients With Leptomeningeal MetastasisRecruitingNCT06417710
- A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have FailedNot yet recruitingNCT06416358Phase 2
- Lattice Radiotherapy for Dose-Escalated Palliation of Bulky TumorsRecruitingNCT06416007Phase 2
- ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)RecruitingNCT06415487Phase 1
- A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyRecruitingNCT06413680Phase 1/2
- Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint InhibitorsRecruitingNCT06408688Phase 4
- Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain MetastasesRecruitingNCT06405256
- Prediction Model of Occult Omental Metastasis in Patients With Gastric CancerRecruitingNCT06405009
- Sacituzumab Govitecan and Bevacizumab for NSCLC Brain MetastasesRecruitingNCT06401824Phase 2
- Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya ReservoirRecruitingNCT06399926
- The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKDNot yet recruitingNCT06398002Phase 2
- clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone MetastasesRecruitingNCT06392217
- Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone MetastasesRecruitingNCT06391242Phase 3
- Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic CarcinomasRecruitingNCT06389123Phase 1
- Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.RecruitingNCT06383780Phase 3
- Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast CancerNot yet recruitingNCT06383663Not applicable
- A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid TumorsNot yet recruitingNCT06383507Phase 1
- Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal FailureNot yet recruitingNCT06378931
- Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain MetastasesNot yet recruitingNCT06374888Phase 2
- HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011RecruitingNCT06369831Phase 2
- National Database of Bone MetastasesRecruitingNCT06367491
- Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid TumorsRecruitingNCT06364410Phase 1
- A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.RecruitingNCT06363773Not applicable
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyRecruitingNCT06362369Phase 1/2
- Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid TumorsRecruitingNCT06358677Phase 2
- Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast CancerRecruitingNCT06358625
- Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) ScanRecruitingNCT06358222
- Longitudinal Study of Local Ablative Therapy in Oligometastatic DiseaseRecruitingNCT06356779Not applicable
- An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain MetastasisRecruitingNCT06352502
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
- Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOXRecruitingNCT06349278Not applicable
- Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric AdenocarcinomasRecruitingNCT06346197Phase 3
- A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal MetastasisRecruitingNCT06339242Phase 2
- Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIRecruitingNCT06333314Phase 2
- A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal MetastasisRecruitingNCT06332287Phase 2
- Brain Metastasis Development Mechanism in BCBM PatientsRecruitingNCT06330870Not applicable
- Anesthesia and Non-small Cell Lung Cancer RecurrenceRecruitingNCT06330038Phase 4
- Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain MetastasesRecruitingNCT06328686Early Phase 1
- Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.RecruitingNCT06321640
- Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06320405Phase 1/2
- High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain MetastasesNot yet recruitingNCT06319950Phase 2
- Surgical Resection Outcomes in Patients With Brain MetastasisRecruitingNCT06318065
- Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)RecruitingNCT06311214Phase 2
- UNC Metastatic Cancer Radiation Therapy RegistryRecruitingNCT06306924
- Pemigatinib + Afatinib in Advanced Refractory Solid TumorsRecruitingNCT06302621Phase 1
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish AvatarsRecruitingNCT06270017Phase 1/2
- Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary MetastasesRecruitingNCT06265350Not applicable
- High Impact Training to Patients with Prostate Cancer and Bone MetastasesRecruitingNCT06259279Not applicable
- A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid TumorsRecruitingNCT06244771Phase 1/2
- The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal MetastasisRecruitingNCT06244264Not applicable
- WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain MetastasesRecruitingNCT06243003Phase 1/2
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid CarcinomaRecruitingNCT06241092
- A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2RecruitingNCT06240728Phase 1
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141RecruitingNCT06235437Phase 1
- Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT SimulationNot yet recruitingNCT06235034Not applicable
- A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell CarcinomaRecruitingNCT06234605Phase 1
- Imaging Guided Cementoplasty for Pelvic Bone MetastasisNot yet recruitingNCT06231628Not applicable
- Development and Validation of a PSN-AI Prediction ModelRecruitingNCT06231524
- a Feasibility Study of iHD-SRT for BMRecruitingNCT06231186Not applicable
- Single-isocenter SBRT vs. Multiple-isocenter SBRT for Multiple Extracranial MetastasesRecruitingNCT06230666Not applicable
- Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery EmbolizationRecruitingNCT06228677
- Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver MetastasisRecruitingNCT06225843Phase 2
- Studying TAK-243 in Patients With Advanced CancerRecruitingNCT06223542Phase 1
- A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic AcidNot yet recruitingNCT06221072Phase 3
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal MetastasisNot yet recruitingNCT06213519Phase 2
- SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain MetastasesNot yet recruitingNCT06210438Phase 2
- MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver MetastasesRecruitingNCT06208397
- Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung CancerRecruitingNCT06207292Not applicable
- Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant MalignanciesNot yet recruitingNCT06205901
- Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics ModelRecruitingNCT06202404
- Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast CancerRecruitingNCT06201234Phase 2
- ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer PatientsRecruitingNCT06195709Phase 3